Home

Anna Protopapas, Director: Mersana Therapeutics MRSN Sell · Filed 25/01/17

Trade details

Type
Insider sale
Amount
$5,009.46
Shares · price
8,637 sh · $0.58 a share
Held after
168,041 sh
Trade date
25/01/16
Filed
25/01/17
Days to filing
1 days

Sold 4.9% of holdings

Share of holding sold
4.9%

Mersana Therapeutics trades, last 26 weeks

What else happened in Mersana Therapeutics around then

Filed or reported within 30 days of the trade day · 24/12/17~25/02/15

Anna Protopapas's recent trades

  • Anna Protopapas

    Sell10b5-1 planMersana Therapeutics

    $3,900

    Filed 25/01/16

  • Anna Protopapas

    Sell10b5-1 planMersana Therapeutics

    $7,612

    Filed 25/01/15

  • Anna Protopapas

    Sell10b5-1 planMersana Therapeutics

    $79.7K

    Filed 24/01/17

  • Anna Protopapas

    SellNuvalent

    $378.4K

    Filed 23/12/20

  • Anna Protopapas

    SellMersana Therapeutics

    $99.6K

    Filed 23/01/18

Anna Protopapas, Director — sold $5,009 of Mersana Therapeutics MRSN · 4.9% of holdings · 10b5-1 plan | Whalegun